Detalhe da pesquisa
1.
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
Muscle Nerve
; 67(5): 354-362, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533976
2.
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).
Muscle Nerve
; 67(6): 456-463, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929648